A. Ohneda, H. Takahashi, and Y. Maruyama, Response of plasma glicentin to fat ingestion in piglets, Diabetes Research and Clinical Practice, vol.3, issue.2, pp.103-112, 1987.
DOI : 10.1016/S0168-8227(87)80014-1

R. Tadokoro, T. Shimizu, A. Hosaka, N. Kaneko, Y. Satoh et al., Postnatal and postprandial changes in plasma concentrations of glicentin in term and preterm infants, Acta Paediatrica, vol.1, issue.10, pp.1175-1184, 2003.
DOI : 10.1111/j.1651-2227.2003.tb02480.x

T. Shimizu, R. Tadokoro, N. Kaneko, M. Suzuki, K. Tanaka et al., Effects of extremely early enteral feeding on plasma glicentin levels in very-low-birthweight infants, Journal of Paediatrics and Child Health, vol.17, issue.10, pp.636-645, 2006.
DOI : 10.1097/00075197-200111000-00015

C. Orskov, J. Jeppesen, S. Madsbad, and J. Holst, Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine., Journal of Clinical Investigation, vol.87, issue.2, pp.415-438, 1991.
DOI : 10.1172/JCI115012

H. Naito, A. Ohneda, R. Kojima, T. Sato, K. Sasaki et al., Plasma glicentin in diabetic and gastrectomized patients, Regulatory Peptides, vol.79, issue.1, pp.55-61, 1999.
DOI : 10.1016/S0167-0115(98)00144-X

A. Ohneda, T. Kobayashi, and J. Nihei, Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs, Diabetologia, vol.1, issue.Suppl 2, pp.397-401, 1986.
DOI : 10.1007/BF00903352

H. Buchwald, R. Estok, K. Fahrbach, D. Banel, M. Jensen et al., Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis, The American Journal of Medicine, vol.122, issue.3, pp.248-56, 2009.
DOI : 10.1016/j.amjmed.2008.09.041

A. Acc, TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society, Circulation, vol.129, issue.25 2, pp.102-140, 2014.

H. Buchwald and D. Oien, Metabolic/Bariatric Surgery Worldwide 2008, Obesity Surgery, vol.196, issue.12, pp.1605-1616, 2008.
DOI : 10.1007/s11695-009-0014-5

M. Piche, A. Auclair, J. Harvey, S. Marceau, and P. Poirier, How to Choose and Use Bariatric Surgery in 2015, Canadian Journal of Cardiology, vol.31, issue.2, pp.153-66, 2015.
DOI : 10.1016/j.cjca.2014.12.014

J. Holst, Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery, Current Opinion in Pharmacology, vol.13, issue.6, pp.983-991, 2013.
DOI : 10.1016/j.coph.2013.09.014

D. Papamargaritis, A. Miras, and C. Le-roux, Influence of diabetes surgery on gut hormones and incretins, Nutr Hosp, vol.28, issue.2, pp.95-103, 2013.

V. Ionut, M. Burch, A. Youdim, and R. Bergman, Gastrointestinal hormones and bariatric surgery-induced weight loss, Obesity, vol.244, issue.2 Suppl, pp.1093-103, 2013.
DOI : 10.1002/oby.20364

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423817

C. Dirksen, N. Jorgensen, K. Bojsen-moller, S. Jacobsen, D. Hansen et al., Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass, Diabetologia, vol.46, issue.Suppl. 1, pp.1890-901, 2012.
DOI : 10.1007/s00125-012-2556-7

L. Baggio and D. Drucker, Biology of Incretins: GLP-1 and GIP, Gastroenterology, vol.132, issue.6, pp.2131-57, 2007.
DOI : 10.1053/j.gastro.2007.03.054

J. Holst and . Enteroglucagon, ENTEROGLUCAGON, Annual Review of Physiology, vol.59, issue.1, pp.257-71, 1997.
DOI : 10.1146/annurev.physiol.59.1.257

M. Hage, B. Safadi, I. Salti, and M. Nasrallah, Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery, ISRN Endocrinology, vol.4, issue.1
DOI : 10.1007/s00464-008-0069-8

P. Sala, R. Torrinhas, D. Giannella-neto, and D. Waitzberg, Relationship between gut hormones and glucose homeostasis after bariatric surgery, Diabetology & Metabolic Syndrome, vol.6, issue.1, p.87, 2014.
DOI : 10.1186/1758-5996-6-87

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141947

P. Kirkegaard, A. Moody, J. Holst, F. Loud, P. Olsen et al., Glicentin inhibits gastric acid secretion in the rat, Nature, vol.14, issue.5862, pp.156-163, 1982.
DOI : 10.1038/297156a0

S. Myojo, T. Tsujikawa, M. Sasaki, Y. Fujiyama, and T. Bamba, Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro, Journal of Gastroenterology, vol.3, issue.Suppl 2, pp.300-305, 1997.
DOI : 10.1007/BF02934484

S. Pellissier, K. Sasaki, D. Le-nguyen, D. Bataille, and C. Jarrousse, Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine, Neurogastroenterology and Motility, vol.67, issue.4, pp.455-63, 2004.
DOI : 10.1210/en.140.1.22

R. Tomita, S. Igarashi, K. Tanjoh, and S. Fujisaki, Role of recombinant human glicentin in the normal human jejunum: an in vitro study, Hepatogastroenterology, vol.52, issue.65, pp.1459-62, 2005.

A. Ohneda, K. Ohneda, T. Nagasaki, and K. Sasaki, Insulinotropic action of human glicentin in dogs, Metabolism, vol.44, issue.1, pp.47-51, 1995.
DOI : 10.1016/0026-0495(95)90288-0

H. Naito, A. Ohneda, R. Kojima, T. Sato, K. Sasaki et al., Plasma glicentin in diabetic and gastrectomized patients, Regulatory Peptides, vol.79, issue.1, pp.55-61, 1999.
DOI : 10.1016/S0167-0115(98)00144-X

N. Wewer-albrechtsen, R. Kuhre, S. Torang, and J. Holst, The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs, BMC Research Notes, vol.91, issue.1, p.60, 2016.
DOI : 10.1186/s13104-016-1872-2

G. Rodier, R. Magous, T. Mochizuki, L. Nguyen, D. Martinez et al., Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes, Endocrinology, vol.140, issue.1, pp.22-30, 1999.

S. Ayachi, F. Borie, R. Magous, K. Sasaki, D. Le-nguyen et al., Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9-39), Neurogastroenterology and Motility, vol.55, issue.2, pp.302-311, 2005.
DOI : 10.1210/jc.2004-0189

URL : https://hal.archives-ouvertes.fr/hal-00358720

I. Quercia, R. Dutia, D. Kotler, S. Belsley, and B. Laferrere, Gastrointestinal changes after bariatric surgery, Diabetes & Metabolism, vol.40, issue.2, pp.87-94, 2014.
DOI : 10.1016/j.diabet.2013.11.003

N. Rhee, C. Wahlgren, J. Pedersen, B. Mortensen, E. Langholz et al., Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes, Diabetologia, vol.3, issue.10, pp.2254-2262, 2015.
DOI : 10.1007/s00125-015-3696-3

F. Zhang, G. Strain, W. Lei, G. Dakin, M. Gagner et al., Changes in Lipid Profiles in Morbidly Obese Patients After Laparoscopic Sleeve Gastrectomy (LSG), Obesity Surgery, vol.238, issue.12, pp.305-314, 2011.
DOI : 10.1007/s11695-010-0285-x

S. Oliveira-cda, B. Beserra, R. Cunha, A. Brito, R. De-miranda et al., Impact of Roux-en-Y gastric bypass on lipid and inflammatory profiles, Revista do Col??gio Brasileiro de Cirurgi??es, vol.42, issue.5, pp.305-315, 2015.
DOI : 10.1590/0100-69912015005007

A. Ohneda and M. Ohneda, Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas., The Tohoku Journal of Experimental Medicine, vol.155, issue.2, pp.197-204, 1988.
DOI : 10.1620/tjem.155.197

A. Ohneda, T. Kobayashi, and J. Nihei, Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs, Diabetologia, vol.1, issue.Suppl 2, pp.397-401, 1986.
DOI : 10.1007/BF00903352

J. Lamonte, A. M. Stroup, and S. C. Hunt, Long-term mortality after gastric bypass surgery, N Engl J Med, vol.357, issue.8, pp.753-761, 2007.

F. Authier and B. Desbuquois, Glucagon receptors, Cellular and Molecular Life Sciences, vol.65, issue.12, pp.1880-99, 2008.
DOI : 10.1007/s00018-008-7479-6

URL : https://hal.archives-ouvertes.fr/inserm-00289267

L. L. Baggio and D. J. Drucker, Biology of Incretins: GLP-1 and GIP, Gastroenterology, vol.132, issue.6, pp.2131-2157, 2007.
DOI : 10.1053/j.gastro.2007.03.054

D. Bataille, Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology, Journal of Molecular Medicine, vol.127, issue.Endocrinol Meta, pp.673-684, 2007.
DOI : 10.1007/s00109-007-0167-4

URL : https://hal.archives-ouvertes.fr/hal-00175786

D. Bataille and S. Dalle, The forgotten members of the glucagon family, Diabetes Research and Clinical Practice, vol.106, issue.1, pp.1-10, 2014.
DOI : 10.1016/j.diabres.2014.06.010

H. Buchwald, R. Estok, K. Fahrbach, D. Banel, M. D. Jensen et al., Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis, The American Journal of Medicine, vol.122, issue.3, pp.248-256, 2009.
DOI : 10.1016/j.amjmed.2008.09.041

H. Buhmann, C. W. Le-roux, and M. Bueter, The gut???brain axis in obesity, Best Practice & Research Clinical Gastroenterology, vol.28, issue.4, pp.559-571, 2014.
DOI : 10.1016/j.bpg.2014.07.003

D. Burrin, Y. Petersen, B. Stoll, and P. Sangild, Glucagon-like peptide 2: a nutrientresponsive gut growth factor, J Nutr, vol.131, issue.3, pp.709-721, 2001.

B. Caballero, The Global Epidemic of Obesity: An Overview, Epidemiologic Reviews, vol.29, issue.1, pp.1-5, 2007.
DOI : 10.1093/epirev/mxm012

J. M. Chevallier, [From bariatric to metabolic surgery: 15 years experience in a French university hospital], Bull Acad Natl Med, vol.194, issue.1, pp.25-36, 2010.

M. Chiba, Y. Sanada, S. Kawano, M. Murofushi, I. Okada et al., Glicentin inhibits internalization of enteric bacteria by cultured INT-407 enterocytes, Pediatric Surgery International, vol.24, issue.6, pp.551-554, 2007.
DOI : 10.1007/s00383-007-1895-9

D. Cottam, F. G. Qureshi, S. G. Mattar, S. Sharma, S. Holover et al., Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity, Surgical Endoscopy, vol.183, issue.6, pp.859-863, 2006.
DOI : 10.1007/s00464-005-0134-5

I. Diouf, M. A. Charles, P. Ducimetiere, A. Basdevant, E. Eschwege et al., Evolution of Obesity Prevalence in France, Epidemiology, vol.21, issue.3, pp.360-365, 2010.
DOI : 10.1097/EDE.0b013e3181d5bff5

URL : https://hal.archives-ouvertes.fr/inserm-00559257

C. Dirksen, N. B. Jorgensen, K. N. Bojsen-moller, S. H. Jacobsen, D. L. Hansen et al., Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass, Diabetologia, vol.46, issue.Suppl. 1, pp.1890-1901, 2012.
DOI : 10.1007/s00125-012-2556-7

J. L. Griggs, P. Sinnayah, and M. L. Mathai, Prader???Willi syndrome: From genetics to behaviour, with special focus on appetite treatments, Neuroscience & Biobehavioral Reviews, vol.59, pp.155-172, 2015.
DOI : 10.1016/j.neubiorev.2015.10.003

M. P. Hage, B. Safadi, I. Salti, and M. Nasrallah, Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery, ISRN Endocrinology, vol.4, issue.1, p.504756, 2012.
DOI : 10.1007/s00464-008-0069-8

N. Hashimoto, H. Ohyanagi, and S. Kazuyuki, Effect of glicentin on gut mucosal growth in rats with jejunal and ileal Thiry-vella fistulas, Journal of Pediatric Surgery, vol.38, issue.4, pp.579-584, 2003.
DOI : 10.1053/jpsu.2003.50126

J. J. Holst, ENTEROGLUCAGON, Annual Review of Physiology, vol.59, issue.1, pp.257-271, 1997.
DOI : 10.1146/annurev.physiol.59.1.257

J. J. Holst, Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery, Current Opinion in Pharmacology, vol.13, issue.6, pp.983-988, 2013.
DOI : 10.1016/j.coph.2013.09.014

E. C. Hoyt, P. K. Lund, D. E. Winesett, C. R. Fuller, M. A. Ghatei et al., Effects of Fasting, Refeeding, and Intraluminal Triglyceride on Proglucagon Expression in Jejunum and Ileum, Diabetes, vol.45, issue.4, pp.434-439, 1996.
DOI : 10.2337/diab.45.4.434

H. Hui, L. Farilla, P. Merkel, and R. Perfetti, The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects, European Journal of Endocrinology, vol.146, issue.6, pp.863-872, 2002.
DOI : 10.1530/eje.0.1460863

V. Ionut, M. Burch, A. Youdim, and R. N. Bergman, Gastrointestinal hormones and bariatric surgery-induced weight loss, Obesity, vol.244, issue.2 Suppl, pp.1093-1103, 2013.
DOI : 10.1002/oby.20364

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423817

N. Irwin and P. R. Flatt, Enteroendocrine hormone mimetics for the treatment of obesity and diabetes, Current Opinion in Pharmacology, vol.13, issue.6, pp.989-995, 2013.
DOI : 10.1016/j.coph.2013.09.009

V. S. Hu, J. M. Hubbard, R. F. Jakicic, C. M. Kushner, B. E. Loria et al., American College of Cardiology/American Heart Association Task Force on Practice and S2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society, Obesity J Am Coll Cardiol, vol.6325, pp.2985-3023, 2014.

P. G. Kopelman, Obesity as a medical problem, Nature, vol.404, issue.6778, pp.635-643, 2000.

L. Marchand, L. , L. R. Wilkens, and M. P. Mi, Obesity in youth and middle age and risk of colorectal cancer in men, Cancer Causes & Control, vol.128, issue.4, pp.349-354, 1992.
DOI : 10.1007/BF00146888

C. M. Lee, P. T. Cirangle, and G. H. Jossart, Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results, Surgical Endoscopy, vol.106, issue.7, pp.1810-1816, 2007.
DOI : 10.1007/s00464-007-9276-y

J. Lovshin and D. J. Drucker, New frontiers in the biology of GLP-2, Regulatory Peptides, vol.90, issue.1-3, pp.1-327, 2000.
DOI : 10.1016/S0167-0115(00)00117-8

H. Manell, J. Staaf, L. Manukyan, H. Kristinsson, J. Cen et al., Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.3, pp.1181-1189, 2016.
DOI : 10.1210/jc.2015-3885

L. C. Melo, M. A. Silva, and A. C. Calles, Obesity and lung function: a systematic review, Einstein (S??o Paulo), vol.12, issue.1, pp.120-125, 2014.
DOI : 10.1590/S1679-45082014RW2691

M. A. Moyad, Obesity, interrelated mechanisms, and exposures and kidney cancer, Semin Urol Oncol, vol.19, issue.4, pp.270-279, 2001.

A. Mozumdar and G. Liguori, Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999-2006, Diabetes Care, vol.34, issue.1, pp.216-219, 2011.
DOI : 10.2337/dc10-0879

K. G. Murphy and S. R. Bloom, Gut hormones and the regulation of energy homeostasis, Nature, vol.243, issue.7121, pp.854-859, 2006.
DOI : 10.1038/nature05484

S. Myojo, T. Tsujikawa, M. Sasaki, Y. Fujiyama, and T. Bamba, Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro, Journal of Gastroenterology, vol.3, issue.Suppl 2, pp.300-305, 1997.
DOI : 10.1007/BF02934484

S. Shibata, I. Matsuno, and . Sasaki, Plasma glicentin in diabetic and gastrectomized patients, Regul Pept, vol.79, issue.1, pp.55-61, 1999.

A. Ohneda, Response of plasma glicentin to intraduodenal administration of glucose in piglets, Diabetes Research and Clinical Practice, vol.3, issue.2, pp.97-102, 1987.
DOI : 10.1016/S0168-8227(87)80013-X

A. Ohneda, T. Kobayashi, and J. Nihei, Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs, Diabetologia, vol.1, issue.Suppl 2, pp.397-401, 1986.
DOI : 10.1007/BF00903352

A. Ohneda, T. Kobayashi, J. Nihei, and H. Takahashi, Effect of intraluminal administration of amino acids upon plasma glicentin, Diabetes Research and Clinical Practice, vol.5, issue.4, pp.265-270, 1988.
DOI : 10.1016/S0168-8227(88)80061-5

A. Ohneda, K. Ohneda, T. Nagasaki, and K. Sasaki, Insulinotropic action of human glicentin in dogs, Metabolism, vol.44, issue.1, pp.47-51, 1995.
DOI : 10.1016/0026-0495(95)90288-0

A. Ohneda and M. Ohneda, Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas., The Tohoku Journal of Experimental Medicine, vol.155, issue.2, pp.197-204, 1988.
DOI : 10.1620/tjem.155.197

C. Orskov, J. Jeppesen, S. Madsbad, and J. J. Holst, Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine., Journal of Clinical Investigation, vol.87, issue.2, pp.415-423, 1991.
DOI : 10.1172/JCI115012

R. Padidela, M. Patterson, N. Sharief, M. Ghatei, and K. Hussain, Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period, European Journal of Endocrinology, vol.160, issue.1, pp.53-61, 2009.
DOI : 10.1530/EJE-08-0807

D. Papamargaritis, A. D. Miras, and C. W. Le-roux, Influence of diabetes surgery on gut hormones and incretins, Nutr Hosp, vol.28, issue.2, pp.95-103, 2013.

S. Pellissier, K. Sasaki, D. Le-nguyen, D. Bataille, and C. Jarrousse, Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine, Neurogastroenterology and Motility, vol.67, issue.4, pp.455-463, 2004.
DOI : 10.1210/en.140.1.22

M. E. Piche, A. Auclair, J. Harvey, S. Marceau, and P. Poirier, How to Choose and Use Bariatric Surgery in 2015, Canadian Journal of Cardiology, vol.31, issue.2, pp.153-166, 2015.
DOI : 10.1016/j.cjca.2014.12.014

A. Pocai, Unraveling oxyntomodulin, GLP1's enigmatic brother, Journal of Endocrinology, vol.215, issue.3, pp.335-381, 2012.
DOI : 10.1530/JOE-12-0368

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493657

A. Gil-guillen and . Group, Prognostic value of obesity on both overall mortality and cardiovascular disease in the general population, Vascular Diseases from PLoS One, vol.10, issue.5, p.127369, 2015.

B. M. Popkin and P. Gordon-larsen, The nutrition transition: worldwide obesity dynamics and their determinants, International Journal of Obesity, vol.28, issue.3, pp.2-9, 2004.
DOI : 10.1038/sj.ijo.0802804

W. J. Pories, M. S. Swanson, K. G. Macdonald, S. B. Long, P. G. Morris et al., Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus, Annals of Surgery, vol.222, issue.3, pp.339-350, 1995.
DOI : 10.1097/00000658-199509000-00011

S. Reuter and R. Mrowka, The metabolic syndrome: the future is now, Acta Physiologica, vol.372, issue.Suppl 1, pp.291-294, 2015.
DOI : 10.1111/apha.12530

G. Rodier, R. Magous, T. Mochizuki, D. Le-nguyen, J. Martinez et al., Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes, Endocrinology, vol.140, issue.1, pp.22-28, 1999.

P. C. Sala, R. S. Torrinhas, D. Giannella-neto, and D. L. Waitzberg, Relationship between gut hormones and glucose homeostasis after bariatric surgery, Diabetology & Metabolic Syndrome, vol.6, issue.1, p.87, 2014.
DOI : 10.1186/1758-5996-6-87

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141947

D. A. Sandoval and D. A. , Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease, Physiological Reviews, vol.95, issue.2, pp.513-548, 2015.
DOI : 10.1152/physrev.00013.2014

M. L. Schubert, Gastric secretion, Current Opinion in Gastroenterology, vol.30, issue.6, pp.578-82, 2014.
DOI : 10.1097/MOG.0000000000000125

E. M. Sinclair and D. J. Drucker, Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential, Physiology, vol.20, issue.5, pp.357-365, 2005.
DOI : 10.1152/physiol.00030.2005

B. A. Stoll, Upper abdominal obesity, insulin resistance and breast cancer risk, Int J Obes Relat Metab Disord, vol.26, issue.6, pp.747-753, 2002.

T. Tan and S. Bloom, Gut hormones as therapeutic agents in treatment of diabetes and obesity, Current Opinion in Pharmacology, vol.13, issue.6, pp.996-1001, 2013.
DOI : 10.1016/j.coph.2013.09.005

H. I. Thieden, J. J. Holst, J. Dich, A. Moody, and F. Sundby, Effect of highly purified porcine gut glucagon-like immunoreactivity (glicentin) on glucose release from isolated rat hepatocytes, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.675, issue.2, pp.163-170, 1981.
DOI : 10.1016/0304-4165(81)90222-1

B. Thorens, Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1., Proceedings of the National Academy of Sciences, vol.89, issue.18, pp.8641-8646, 1992.
DOI : 10.1073/pnas.89.18.8641

R. Tomita, S. Igarashi, K. Tanjoh, and S. Fujisaki, Role of recombinant human glicentin in the normal human jejunum: an in vitro study, Hepatogastroenterology, vol.52, issue.65, pp.1459-1462, 2005.